The National Institutes of Health has awarded $8.67 million to Texas Biomedical Research Institute in San Antonio and Mymetics Corporation of Switzerland to collaborate on the development of an HIV vaccine. Mymetics, a Swiss-based biotechnology company which has a research lab in the Netherlands, focuses on the development of next-generation preventative vaccines for infectious and…